切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (06) : 685 -691. doi: 10.3877/cma.j.issn.1673-5250.2021.06.010

论著

妊娠期生殖道感染所致产科脓毒症合并羊水栓塞分析并文献复习
吴晓兰1,2,1,2, 刘辉1,,1()   
  • 收稿日期:2021-10-16 修回日期:2021-11-07 出版日期:2021-12-01
  • 通信作者: 刘辉

Obstetric sepsis due to reproductive tract infection during pregnancy combined with amniotic fluid embolism: a case report and literature review

Xiaolan Wu1,2,1,2, Hui Liu1,1,()   

  • Received:2021-10-16 Revised:2021-11-07 Published:2021-12-01
  • Corresponding author: Hui Liu
  • Supported by:
    Key Research and Development Project of Science and Technology Department of Sichuan Province(2018SZ0260)
引用本文:

吴晓兰, 刘辉. 妊娠期生殖道感染所致产科脓毒症合并羊水栓塞分析并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 685-691.

Xiaolan Wu, Hui Liu. Obstetric sepsis due to reproductive tract infection during pregnancy combined with amniotic fluid embolism: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(06): 685-691.

目的

探讨妊娠期生殖道感染(RTI)所致产科脓毒症合并羊水栓塞(AFE)患者的临床表现、诊断、治疗及预后,并进行相关文献复习。

方法

选择2021年9月,于成都市第五人民医院住院、分娩的1例临床诊断为妊娠期生殖道光滑念珠菌感染所致产科脓毒症合并AFE患者为研究对象。采用回顾性研究方法,收集本例患者的临床病例资料,并对其临床表现、诊断及治疗经过进行分析。以"妊娠期生殖道感染""产科脓毒症""羊水栓塞""reproductive tract infection during pregnancy""obstetric sepsis""amniotic fluid embolism"为关键词,在中国生物医学文献数据库(CBM)、中国知网(CNKI)、维普中文科技期刊数据库、万方数据知识服务平台及PubMed与Ovid Medline数据库中,检索妊娠期RTI所致产科脓毒症合并AFE相关文献。文献检索时间设定为上述数据库建库至2021年10月。总结妊娠期RTI所致产科脓毒症合并AFE患者的临床表现、诊断与治疗。本研究遵循的程序符合2013年新修订的《世界医学协会赫尔辛基宣言》要求。

结果

①本例患者分娩年龄为38岁,2021年9月8日7:20 am,因"停经31+1周,反复阴道流血12+ h,加重2 h",于病例收集医院住院治疗。入院时,胎儿超声检查结果提示,宫内单活胎、头位、胎盘前置;患者血常规提示,白细胞计数、中性粒细胞百分比均增高,分别为11.6×109/L与94.5%;阴道分泌物病原体培养与鉴定结果提示,光滑念珠菌感染。入院当天9:40 am,患者体温为37.9 ℃,采取头孢呋辛抗感染治疗、硫酸镁保护胎儿中枢神经系统、地塞米松促胎肺成熟等对症支持治疗。入院第2天,为进一步明确感染源,持续面罩吸氧下拟进行胸部CT时,患者突发呼吸困难,阴道大量羊水流出,10 min后,患者全身发绀、瘫软,四肢厥冷、牙关紧闭、意识丧失,立即进行气管插管、心电监护提示:脉搏为120次/min,血压为74 mmHg/42 mmHg(1 mmHg=0.133 kPa),脉搏血氧饱和度(SpO2)为70%,胎心率为57次/min,立即采取急诊剖宫产术分娩。术中母体血常规检查结果提示:血红蛋白为116 g/L(正常),血小板计数为35×109/L(低于正常参考值);凝血酶原时间为19.9 s,国际标准化比值为1.72,部分凝血活酶时间>180.0 s,凝血酶时间>180.0 s,纤维蛋白原降解产物为189.65 μg/mL(均高于正常参考值);纤维蛋白原为0.49 g/L(低于正常参考值)。胸腔积液及血液病原体培养结果均提示,革兰阴性杆菌呈阳性。临床拟诊为脓毒症引起休克,AFE、弥散性血管内凝血(DIC)。遂对其进行全子宫切除术+左侧输卵管切除术(右侧输卵管既往已被切除)。术后转入重症监护病房,在多学科团队协作下,采取连续性肾脏替代疗法(CRRT)稳定内环境、输血治疗、管理血容量、升高血压,糖皮质激素抗炎、抗免疫,曲前列尼尔降低肺动脉压,亚胺培南西司他丁抗感染,抑制胃酸分泌,间断进行血液净化治疗减轻炎症反应,体外膜肺氧合(ECMO)改善氧供及亚低温治疗等。由于患者同时合并产科脓毒症与AFE,病情进展迅速,于产后23 d因抢救无效死亡。②按照本研究制定的文献检索策略进行文献检索结果显示,无一例关于妊娠期RTI所致产科脓毒症合并AFE患者救治的文献报道。

结论

妊娠期RTI发生率高,但是RTI后突发AFE的病例报道罕见。临床对妊娠期RTI孕产妇积极、规范抗感染治疗,可预防产科脓毒症及AFE。对于妊娠期RTI所致产科脓毒症合并AFE患者的治疗,因涉及多器官功能衰竭(MOF),需要多学科团队协作改善患者预后。

Objective

To explore the clinical manifestations, diagnosis, treatment and prognosis of patients with obstetric sepsis due to reproductive tract infection (RTI) during pregnancy combined with amniotic fluid embolism (AFE), and review relevant literature.

Methods

A patient who was clinically diagnosed as obstetric sepsis due to RTI during pregnancy combined with AFE and hospitalized and delivered in Chengdu Fifth People′s Hospital in September 2021 was selected as research subject. Clinical data of this patient were collected by retrospective study method, and her clinical manifestations, diagnosis and treatment were analyzed. Literature about obstetric sepsis due to RTI during pregnancy combined with AFE were retrieved with key words of " reproductive tract infection during pregnancy" " obstetric sepsis" and " amniotic fluid embolism" both in Chinese and English, based on China Biology Medicine (CBM), China National Knowledge Infrastructure (CNKI), VIP, Wanfang Data Service Platform, PubMed and Ovid Medline database. Literature retrieval time was set from the establishment of above databases to October 2021. Clinical manifestations, diagnosis and treatment of obstetric sepsis due to RTI during pregnancy combined with AFE were summarized. The procedures followed in this study were in line with the requirements of World Medical Association Declaration of Helsinki revised in 2013.

Results

①This patient was 38 year old at childbirth who admitted to case collected hospital due to " menopause 31+ 1 week, recurrent vaginal bleeding 12+ h, aggravation 2 h" at 7: 20 am on September 8, 2021. On admission, results of fetal ultrasonography indicated that intrauterine single live fetus with head presentation, and placenta previa; maternal blood routine examination indicated that white blood cell count and percentage of neutrophils both were increased, which were 11.6×109/L and 94.5%, respectively; vaginal secretion culture and identification results indicated that the patient was infected with Candida glabrata. At 9: 40 am on the day of admission, the patient′s body temperature was 37.9 ℃, and cefuroxime was given for anti-infective therapy, magnesium sulfate was used to protect fetal central nervous system, and dexamethasone was used to promote fetal lung maturity. On the second day after admission, when chest CT was planned to be performed under continuous mask oxygen inhalation to further clarify the source of infection, the patient had sudden dyspnea and a large amount of vaginal amniotic fluid flowed out, and 10 minutes later, she developed cyanosis all over the body with cold limbs, paralysis, lockjaw and loss of consciousness. Endotracheal intubation was immediately performed, and ECG monitoring suggested that pulse was 120 times/min, blood pressure was 74 mmHg/42 mmHg (1 mmHg=0.133 kPa), pulse oxygen saturation (SpO2) was 70%, fetal heart was 57 times/min, and emergency cesarean section was performed immediately. Intraoperative blood routine examination showed that hemoglobin was normal with 116 g/L and platelet count was 35×109/L, which was lower than the normal reference value; prothrombin time was 19.9 s, international standardized ratio was 1.72, partial thromboplastin time was>180.0 s, thrombin time was>180.0 s, fibrinogen degradation product was 189.65 μg/mL, which all were lower than the normal reference values, and fibrinogen was 0.49 g/L, which was higher than the normal reference value. Results of pleural fluid culture and blood culture showed positive of gram-negative bacilli, and septic shock was considered. Total hysterectomy and left salpingectomy were performed for the diagnosis of septic shock caused by sepsis, AFE and disseminated intravascular coagulation (DIC). After operation, she was transferred to intensive care unit. With cooperation of a multidisciplinary team, she was treated by continuous renal replacement therapy (CRRT) to stabilize internal environment, blood transfusion for supplement of blood components, management of blood volume, and increase blood pressure, and glucocorticoids for anti-inflammatory and anti-immune treatment. She was also treated by treprostinil to reduce pulmonary arterial pressure, imipenem and cilastatin for anti-infective treatment, suppression of gastric acid secretion, continuous blood purification to reduce inflammation reaction, and extracorporeal membrane oxygenation (ECMO) to improve oxygen supply and hypothermia treatment, and so on. Because the patient was complicated with septic shock and AFE, and the disease progressed rapidly and was very critical, she died 23 days after delivery due to ineffective rescue. ②According to literature retrieval strategy developed in this study, literature retrieval results showed that there was not a single case of obstetric sepsis due to RTI during pregnancy combined with AFE, so there was no diagnosis and treatment report of related cases so far.

Conclusions

Incidence of RTI during pregnancy is high, but case reports of AFE after RTI are rare. Clinical treatment for patients with RTI during pregnancy should be identified as soon as possible, and actively standardized anti-infection treatment should be taken to reduce the occurrence of obstetric sepsis and AFE. For the treatment of patients with obstetric sepsis due to RTI during pregnancy combined with AFE, a multidisciplinary team is needed to effectively improve patients′ prognosis for patients′ multiple organ failure (MOF).

[1]
林小凤,樊尚荣. "羊水栓塞临床诊断与处理专家共识(2018)"解读[J/CD]. 中华产科急救电子杂志2019, 2(8): 32-37. DOI: 10.3877/cma.j.issn.2095-3259.2019.01.008.
[2]
Society for Maternal-Fetal Medicine (SMFM), Pacheco LD, Saade G, et al. Amniotic fluid embolism: diagnosis and management[J]. Am J Obstet Gynecol, 2016, 215(2): B16-B24. DOI: 10.1016/j.ajog.2016.03.012.
[3]
中华医学会妇产科学分会产科学组. 羊水栓塞临床诊断与处理专家共识(2018)[J]. 中华妇产科杂志2018, 53(12): 831-835. DOI: 10.3760/cma.j.issn.0529-567x.2018.12.006.
[4]
夏伟,周容. 2019年母胎医学会"妊娠和产褥期脓毒症管理指南"解读[J]. 实用妇产科杂志2020, 36(1): 17-20.
[5]
中国成人念珠菌病诊断与治疗专家共识组. 中国成人念珠菌病诊断与治疗专家共识[J]. 中华内科杂志2020, 59(1): 5-17. DOI: 10.3760/cma.j.issn.0578-1426.2020.01.002.
[6]
Society for Maternal-Fetal Medicine (SMFM), Plante LA, Pacheco LD, et al. SMFM Consult Series #47: Sepsis during pregnancy and the puerperium[J]. Am J Obstet Gynecol, 2019, 220(4): B2-B10. DOI: 10.1016/j.ajog.2019.01.216.
[7]
Kendle AM, Salemi JL, Tanner JP, et al. Delivery-associated sepsis:trends in prevalence and mortality[J]. Am J Obstet Gynecol, 2019, 220(4): 391.e1-391.e16. DOI: 10.1016/j.ajog.2019.02.002.
[8]
Committee Opinion No.712: intrapartum management of intraamniotic infection[J]. Obstet Gynecol, 2017, 130(2): e95-e101. DOI: 10.1097/AOG.0000000000002236.
[9]
陈磊,刘朝晖. 绒毛膜羊膜炎的致病菌及药敏分析[J]. 中国妇产科临床杂志2016, 17(2): 140-143. DOI: 10.13390/j.issn.1672-1861.2016.02.013.
[10]
贺芳,陈敦金. 产科感染性休克的诊治[J]. 中国实用妇科与产科杂志2016, 32(12): 1185-1188. DOI: 10.7504/fk2016110112.
[11]
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287.
[12]
中国医师协会急诊医师分会,中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 中国急救医学2018, 38(9): 741-756. DOI: 10.3969/j.issn.1002-1949.2018.09.001.
[13]
Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock[J]. Lancet, 2018, 392(10141): 75-87. DOI: 10.1016/S0140-6736(18)30696-2.
[14]
Bowyer L, Robinson HL, Barrett H, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy[J]. Aust N Z J Obstet Gynaecol, 2017, 57(5): 540-551. DOI: 10.1111/ajo.12646.
[15]
Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, et al. Incidence,risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study[J]. BJOG, 2016, 123(1): 100-109. DOI: 10.1111/1471-0528.13300.
[16]
Moaddab A, Klassen M, Priester CD, et al. Reproductive decisions after the diagnosis of amniotic fluid embolism[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 211: 33-36. DOI: 10.1016/j.ejogrb.2017.01.050.
[17]
周玮,漆洪波. 美国母胎医学会羊水栓塞指南(2016)要点解读[J]. 中国实用妇科与产科杂志2016, 32(9): 865-866. DOI: 10.7504/fk2016080112.
[18]
马驰宇,何泽琳,段燕婷,等. 羊水栓塞诊疗进展[J]. 妇产与遗传(电子版), 2021, 6(11): 48-49. DOI: 10.3868/j.issn.2095-1558.2021.02.010.
[19]
李海冰,刘志强. 术中自体血液回输在产科中应用的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2018, 14(5): 617-620. DOI: 10.3877/cma.j.issn.1673-5250.2018.05.021.
[20]
汪彦燕,黄仁瑛. 孕产妇死亡原因分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2014, 10(3): 367-369. DOI: 10.3877/cma.j.issn.1673-5250.2014.03.023.
[21]
郎艳. 未足月胎膜早破患者易发因素分析及其妊娠结局研究[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(6): 724-728. DOI: 10.3877/cma.j.issn.1673-5250.2015.06.010.
[1] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[2] 孟建标, 张庚, 焦燕娜. 脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 279-285.
[3] 陈宇, 冯芳, 张露, 刘健. 基于生物信息学分析筛选脓毒症心肌病关键致病基因[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 286-291.
[4] 莫小乔, 胡喆莹, 廖冬花, 谢天. 脓毒症继发急性肾损伤患者死亡风险预测模型构建及评估[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 198-206.
[5] 危玲, 李会, 陈奕. 孕产妇产超广谱β-内酰胺酶的肠杆菌定植/感染与母婴传播研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 517-521.
[6] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[7] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[8] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[9] 李振华, 解宝江, 易为, 李丽, 卫雅娴, 周明书, 伊诺. 82例孕产妇对新型冠状病毒肺炎疫情防控认知的心理干预及常态化疫情防控应对要点[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 173-179.
[10] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[11] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[12] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[13] 李世明, 黄蔚, 刘玲. HMGB1介导脓毒症相关凝血功能障碍的作用机制及其治疗进展[J]. 中华重症医学电子杂志, 2023, 09(03): 269-273.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
阅读次数
全文


摘要